Premium
Three‐month formulation of paliperidone delays relapse in schizophrenia
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30060
Subject(s) - paliperidone palmitate , paliperidone , schizophrenia (object oriented programming) , medicine , placebo , antipsychotic , psychiatry , alternative medicine , pathology
A long‐acting injectable formulation of the antipsychotic paliperidone palmitate significantly delayed time to relapse in a placebo‐controlled study of patients with schizophrenia who had been stabilized on the injectable medication, a new study has found.